Navigation Links
ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
Date:2/13/2008

cells represents an exciting opportunity in cancer therapy," said Dr. John E. Dick. "The ability to target leukemic cancer stem cells while potentially leaving normal stem cells intact may provide a more effective means for increasing survival and decreasing relapse in AML and possibly other forms of leukemia."

"ARIUS is very pleased to collaborate with Dr. John Dick, a pioneer in the cancer stem cell field. Prior to collaborating with Dr. Dick, our CD9 antibody demonstrated potent anti-tumor activity in several pre-clinical solid tumor models. Our antibody also appears to be a specific cancer stem cell inhibitor, suggesting that it may become an important drug and forge new paths for the treatment of cancer," said Dr. Daniel S. Pereira, Vice President of Research of ARIUS. "We have identified large and small animal toxicology models suitable for further studies of AR40A746.2.3 and we are on track in the development of this molecule for human clinical trials."

CD9 is a potential marker of acute myeloid leukemia stem cells (LSC) and

serves as a LSC-specific therapeutic target. Poster Session A, Wednesday,

Feb 13th 2008, from 4:30-6:30 pm in the Concourse Ballroom of the Los

Angeles Marriott.

AR40A746.2.3, a functional antibody that targets CD9, has previously been shown to have anti-tumor and survival benefits in animal models of human breast and pancreatic cancer. CD9 is highly expressed and differentially expressed in AML versus normal stem cells (42.7+10.1% verus 9.9+2.8%). Preliminary experiments show that targeting CD9 with AR40A746.2.3 inhibits human AML outgrowth in the NOD/SCID mouse xenotransplant model. In secondary transplantation experiments, treatments with AR40A746.2.3 dramatically reduced the self-renewal capacity of AML cancer stem cells.

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a propr
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
2. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
3. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
4. ARIUS to present at Chinese Global Financial Forum
5. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
6. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
7. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
8. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
9. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... According to a new market report published by ... was valued at USD 3,754.6 million in 2012 and is ... a CAGR of 5.9% from 2013 to 2019. , Nearly ... afflicted by bone and joint disorders, and this number is ... and will continue to increase the demand for orthobiologics. Other ...
(Date:8/29/2014)... August 29, 2014 Three Lawrence ... 2014 Hydrogen Production R&D Award for ... splitting water using sunlight. , Shared with collaborators ... the University of Nevada, Las Vegas (UNLV), the ... models of photoelectrochemical solar-hydrogen production and corrosion processes. ...
(Date:8/28/2014)... August 28, 2014 SPIE Fellow Glenn ... and Optical Science and Director of the Center for ... Carolina at Charlotte, and co-founder and Chairman of the ... as the 2015 Vice President of SPIE, the international ... Philip Stahl announced recent election results at the Annual ...
(Date:8/28/2014)... research platform uses a laser to measure ... stress and heating, an approach likely to ... and batteries., This new technique, called nanomechanical ... and the surface stress of microscale structures ... the merits of surface-stress influence on mechanical ...
Breaking Biology Technology:Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3Livermore Team Awarded for Hydrogen Production Research 2Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3
... , INDIANAPOLIS, Dec. 16 ... strong growth of Indiana,s life sciences industry and an active ... Indiana State Teachers Retirement Fund, Indiana University, Purdue University, the ... Suisse today announced the establishment of the INext Fund, a ...
... biotechnology company,s revenues increase 22% for fiscal 2009; on ... TORONTO, Dec. 16 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) ... today reported financial results for fourth quarter and full-year ... Microbix reported revenues of $6.08 million, a 22% increase ...
... , Trial conducted pursuant to Special Protocol ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... biopharmaceutical company focused on oncology and endocrine therapy, today ... ("Keryx") ( KERX), of a Phase 3 registration clinical ...
Cached Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5
(Date:8/29/2014)... available in German . ... the natural nitrogen cycle on Earth and in biological ... thought to depend on nitrite as their source of ... Daims, a microbiologist at the University of Vienna, has ... an alternative source of energy. The oxidation of hydrogen ...
(Date:8/29/2014)... City, MO. - In a cell,s nucleus, chromosomal ... as histones, an amalgam biologists call chromatin. Until ... a nuclear "sidekick," the mere packing material around ... however, biologists have developed a greater appreciation for ... 2012, investigators from multiple research institutions studying the ...
(Date:8/28/2014)... app called TX Invasives is now available from the ... Texas at Austin for identifying harmful non-native plant, insect ... in the United States cause about $137 billion in ... crops, clog waterways, kill native plants and more. , ... for reporting where invasive species occur, we,re more likely ...
Breaking Biology News(10 mins):Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 2'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 3Mobile app makes ID of harmful plants, insects in Texas a snap 2
... Children's Research Hospital have discovered that a protein called ABCB6 ... is key to the ability of red blood cells to ... of cells to extract energy from nutrients. , The ... outer membrane of the cell's energy powerhouse called ...
... has successfully protected mice and ferrets against a highly ... led the study at St. Jude Children's Research Hospital. ... Diego, California. , This finding, coupled with results of ... strains, suggests that such a vaccine would protect humans ...
... Mayo Clinic Cancer Center has opened a new clinical ... to attack recurrent glioblastoma multiforme, a largely untreatable brain ... molecular medicine studies in patients using measles to kill ... treat some of the most lethal cancers," says Eva ...
Cached Biology News:ABCB6 is key to production of heme in hemoglobin 2St. Jude test of bird flu vaccine proves successful 2Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer 2Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer 3
Request Info...
Loading Buffer...
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates....
Biology Products: